Thomas Woiwode's Net Worth
Thomas Woiwode's net worth is estimated to be at least $23,737,820.33 as of 05/03/2024. CoreStreet's estimation of Thomas Woiwode's net worth is based on their sale of stock and current holding of stock.
Thomas Woiwode is Director at Tempest Therapeutics Inc. They have executed at least 7 trades of stock as per SEC Form 4 filings. Their most recent trade was for 2,118,644 units of TPST stock on 04/29/2022. Their biggest sale was on 04/27/2018 when they sold 222,258 units of Crispr Therapeutics AG stock for $11,137,348.38. They typically trade 1 times per year.
Total value of insider buys:
- $12,499,999.84
Total value of insider sells:
- $11,237,820.49
Most recent insider trade:
- April 29, 2022
Thomas Woiwode's Insider Trading History
| Tempest Therapeutics Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
April 29, 2022 | Director | 2,118,644 | $2.36 | Buy | $4,999,999.84 |
| Aligos Therapeutics Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Oct. 20, 2020 | Director | 200,000 | $15.00 | Buy | $3,000,000.00 |
| Passage Bio Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
March 3, 2020 | Director | 225,000 | $20.00 | Buy | $4,500,000.00 |
| Crispr Therapeutics AG | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
April 27, 2018 | Director | 222,258 | $50.11 | Sell | $11,137,348.38 |
Dec. 22, 2017 | Director | 3,059 | $20.29 | Sell | $62,067.11 |
Nov. 27, 2017 | Director | 200 | $20.24 | Sell | $4,048.00 |
Nov. 24, 2017 | Director | 1,700 | $20.21 | Sell | $34,357.00 |